- $2.40bn
- $2.89bn
- $1.67bn
- 72
- 41
- 59
- 57
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,185 | 1,176 | 1,511 | 1,757 | 1,665 |
Cost of Revenue | |||||
Gross Profit | 263 | 193 | 284 | 351 | 349 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,115 | 1,168 | 1,434 | 1,637 | 1,529 |
Operating Profit | 70.5 | 8.21 | 77.1 | 120 | 136 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 65.5 | 8.28 | 77.3 | 103 | 108 |
Provision for Income Taxes | |||||
Net Income After Taxes | 53.4 | 15.5 | 72.5 | 86 | 95.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 53.4 | 15.5 | 72.5 | 86 | 95.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 53.4 | 15.5 | 72.5 | 86 | 95.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.19 | 1.58 | 3.47 | 4.68 | 4.74 |
Dividends per Share |